What are the main reasons catheter-associated bacteriuria (CBP) caused by Enterococcus Faecalis can't be fully resolved and cured?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Main Reasons Catheter-Associated Bacteriuria Caused by Enterococcus Faecalis Can't Be Fully Resolved and Cured

The primary reasons catheter-associated bacteriuria (CBP) caused by Enterococcus faecalis is difficult to fully resolve include biofilm formation on catheters, antimicrobial resistance patterns, and catheter retention issues. 1, 2

Biofilm Formation

  • E. faecalis has considerable ability to form biofilms on urinary catheters, creating a protective environment that shields bacteria from antimicrobial agents and host immune responses 3
  • Biofilm formation allows bacteria to adhere to catheter surfaces and produce an extracellular matrix that significantly reduces antibiotic penetration 3
  • All E. faecalis isolates from urinary tract infections have demonstrated biofilm-positive characteristics in laboratory studies 3

Catheter Retention Issues

  • Retention of infected catheters significantly reduces cure rates for E. faecalis infections, with studies showing only 38% cure rate when catheters remain in place versus 83% when removed 2
  • The Infectious Diseases Society of America recommends removal of infected short-term intravascular catheters for enterococcal infections 1
  • For long-term catheters, removal is specifically indicated in cases of insertion site infection, pocket infection, suppurative thrombophlebitis, sepsis, endocarditis, persistent bacteremia, or metastatic infection 1
  • When catheter removal is not feasible, persistent bacteremia beyond 72 hours of appropriate antibiotic therapy is common 1

Antimicrobial Resistance

  • E. faecalis demonstrates increasing resistance to multiple antibiotics, with 60% of E. faecium and 2% of E. faecalis nosocomial bloodstream infections being resistant to vancomycin 1
  • Resistance to newer agents such as linezolid has been reported, further limiting treatment options 1
  • Inappropriate antibiotic use for asymptomatic bacteriuria contributes to the development of resistant strains 1
  • The universal formation of biofilm along indwelling catheters means antimicrobial therapy may delay but not prevent bacteriuria onset 1

Treatment Challenges

  • Monotherapy is often insufficient for catheter-related E. faecalis infections when the catheter remains in place 2
  • Combination therapy with a cell wall-active antimicrobial plus an aminoglycoside is more effective than monotherapy when catheters are retained, but the role of combination therapy remains unresolved 1, 2
  • Enterococcal bacteremia that persists for more than 4 days has been independently associated with increased mortality 1
  • Even with appropriate antimicrobial therapy, recurrence with the same or different species, often with increased antimicrobial resistance, occurs universally when catheters remain in place 1

Complications and Risk Factors

  • Diabetes mellitus, prolonged hospital stays (>28 days), and the presence of a urinary catheter are all factors associated with polymicrobial E. faecalis bacteriuria, which is more difficult to treat 4
  • Polymicrobial infections appear to be more prevalent than monomicrobial E. faecalis infections (42% vs 32%) and are associated with higher treatment failure rates 4
  • The risk of endocarditis as a complication of enterococcal catheter-related bloodstream infection is relatively low (1.5%), but when present significantly complicates treatment 1
  • Persistent fever or positive blood cultures after 72 hours of appropriate therapy indicates a need for catheter removal, but this is not always feasible in patients with limited vascular access 1

Prevention and Management Strategies

  • Antibiotic lock therapy should be used in addition to systemic therapy if the catheter is retained, but this approach alone is insufficient 1
  • Nitrofurazone-impregnated catheters have shown the best antimicrobial durability against E. faecalis biofilms compared to silver-coated or hydrophilic-coated catheters 3
  • Limiting the use and duration of urinary catheterization is the most effective preventive strategy 5
  • For uncomplicated enterococcal catheter-related infections, a 7-14 day course of therapy is recommended when the short-term catheter is removed or when the long-term catheter is retained with antibiotic lock therapy 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.